Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
As of today, Eli Lilly(LLY) shares are valued at $1,078.00. The company's market cap stands at 1.02T, with a P/E ratio of 53.43 and a dividend yield of 55.5%.
On 2026-01-04, Eli Lilly(LLY) stock moved within a range of $1,052.08 to $1,080.65. With shares now at $1,078.00, the stock is trading +2.5% above its intraday low and -0.2% below the session's peak.
Trading volume for Eli Lilly(LLY) stock has reached 2.47M, versus its average volume of 2.34M.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,111.99 and a low of $623.78.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,111.99 and a low of $623.78.
LLY News
Insiders have been trading these 5 stocks: ((LLY)), ((ORCL)), ((HD)), ((TSE:WEED)) and ((RKLB)). Here is a breakdown of their recent trades and their value. Cl...
These two companies have very different risk-reward profiles. Recursion Pharmaceuticals (RXRX 0.49%), a small-cap biotech company, has one claim to fame: It cu...
Biotech and Pharma In the Year of the Weight-Loss Pill, Lilly Still Leads GLP-1s In this article NOVO.B LLY Novo Nordisk and Eli Lilly will introduce pill versi...
Analyst ratings
80%
of 30 ratingsMore LLY News
Dow Jones Futures Fall On 2025's Final Day; Eli Lilly, Shopify Forge Buy Points 12/30/2025 The stock market will enter the final day of 2025 near highs — and k...
...
New insider activity at Eli Lilly & Co ( (LLY) ) has taken place on December 30, 2025. Claim 70% Off TipRanks This Holiday Season Unlock hedge fund-level data a...
Key Points Novo Nordisk's CagriSema could be a brand new growth driver for the company. Eli Lilly's orforglipron is breaking into a new, lucrative market. On...
